Sodium Hydroxide → 2,7-Dichloroquinazolin-4(1H)-one
Reaktionsgleichung
[OH-:1].[Na+].[Cl:3][C:4]1[N:13]=[C:12](Cl)[C:11]2[C:6](=[CH:7][C:8]([Cl:15])=[CH:9][CH:10]=2)[N:5]=1>C1COCC1>[Cl:3][C:4]1[NH:13][C:12](=[O:1])[C:11]2[C:6](=[CH:7][C:8]([Cl:15])=[CH:9][CH:10]=2)[N:5]=1Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Reaktionsbedingungen
- Temperatur
- 0 °C
Versuchsvorschrift
A 1.0 M aqueous solution of sodium hydroxide (19 mL, 19 mmol) was added to a mixture of 2,4,7-trichloroquinazoline (2.0 g, 8.5 mmol) and THF (30 mL) that had been cooled to 0° C. The reaction mixture was allowed to warm to rt and was stirred vigorously for 2 h. The mixture was concentrated to remove the THF, and the remaining aqueous phase was cooled to 0° C. and acidified by addition of 1.0 M aqueous HCl (25 mL). The resulting mixture was allowed to stand at 0° C. for 20 min, the solid was collected by filtration and dried to provide the titled compound (1.7 g, 92%). The MS and NMR data are in agreement with those that have been previously described: Journal of Medicinal Chemistry, 2007, 50, 2297-2300.
Aufarbeitung
- temperatureto warm to rt
- concentrationThe mixture was concentrated
- customto remove the THF
- temperaturethe remaining aqueous phase was cooled to 0° C.
- additionacidified by addition of 1.0 M aqueous HCl (25 mL)
- waitto stand at 0° C. for 20 min
- filtrationthe solid was collected by filtration
- customdried
Quellen und Nachweise
- ORD-Eintrag
- ord-bfa9273320ab40aba28734151d063317
- Quelldatensatz
- uspto-grants-2015_01
- Patentnummer
- US08937078B2
Notizen zur Reaktion
Wird geladen…